Axogen Corporation, founded in 2002, specialises in peripheral nerve regeneration and repair. The company develops and commercialises medical device technologies for surgeons performing nerve repair procedures across a range of clinical applications, including trauma surgery, breast reconstruction, and carpal tunnel revision. Its work addresses a market opportunity estimated at over $2.7 billion.
The company's product portfolio includes the Avance Nerve Graft, the Axoguard Nerve Connector, and the Axoguard Nerve Protector. Each is designed to provide clinically proven solutions for peripheral nerve repair, offering surgeons alternatives that avoid the morbidity associated with traditional autograft harvesting.
With more than 15 years of experience in the field, Axogen operates at the intersection of surgical care and medical device development. The company is headquartered in Florida and focuses exclusively on technologies that support nerve regeneration, positioning it as a specialised player within the broader healthcare and medical devices sector.
